Fresenius SE Long-Term Investments 2016-2024 | FSNUY

Fresenius SE long-term investments from 2016 to 2024. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
  • Fresenius SE long-term investments for the quarter ending September 30, 2024 were $4.121B, a INF% increase year-over-year.
  • Fresenius SE long-term investments for 2023 were $3.788B, a INF% increase from 2022.
  • Fresenius SE long-term investments for 2022 were $0B, a NAN% decline from 2021.
  • Fresenius SE long-term investments for 2021 were $0B, a NAN% decline from 2020.
Fresenius SE Annual Long-Term Investments
(Millions of US $)
2023 $3,788
2022 $
2021 $
2020 $
2019 $
2018 $
2017 $
2016 $
2015 $
Fresenius SE Quarterly Long-Term Investments
(Millions of US $)
2024-09-30 $4,121
2024-06-30 $4,071
2024-03-31 $3,835
2023-12-31 $3,788
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $21.703B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $17.349B 17.58
DaVita (DVA) United States $14.249B 18.43
Encompass Health (EHC) United States $9.629B 22.70
Chemed (CHE) United States $8.394B 25.80
Elanco Animal Health (ELAN) United States $6.076B 14.46
Option Care Health (OPCH) United States $5.267B 24.96
RadNet (RDNT) United States $4.972B 110.11
LifeStance Health (LFST) United States $3.092B 0.00
Amedisys (AMED) United States $3.023B 21.51
Addus HomeCare (ADUS) United States $2.290B 26.87
Astrana Health (ASTH) United States $2.076B 28.39
U.S Physical Therapy (USPH) United States $1.337B 35.14
Pennant (PNTG) United States $0.945B 38.21
Aveanna Healthcare Holdings (AVAH) United States $0.945B 0.00
Atai Life Sciences (ATAI) Germany $0.252B 0.00
Bioqual (BIOQ) United States $0.055B 0.00
Daxor (DXR) United States $0.038B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.004B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00